CryoLife Company Profile (NYSE:CRY)

About CryoLife (NYSE:CRY)

CryoLife logoCryoLife, Inc. (CryoLife) is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in cardiac surgical procedures. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as BioGlue Surgical Adhesive, BioFoam Surgical Matrix, On-X Life Technologies Holdings, Inc. valves and surgical products, CardioGenesis cardiac laser therapy product line, PerClot and PhotoFix. PhotoFix is a pericardial patch stabilized using a dye-mediated photo-fixation process that requires no glutaraldehyde. The Preservation Services segment includes external services, such as preservation of cardiac and vascular tissues. The cardiac and vascular human tissues distributed by CryoLife include the CryoValve SG pulmonary heart valve and the CryoPatch SG pulmonary cardiac patch, both of which are processed using CryoLife's SynerGraft technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: Health Care Equipment
  • Symbol: NYSE:CRY
  • CUSIP: 22890310
  • Web:
  • Market Cap: $682.3 million
  • Outstanding Shares: 33,446,000
Average Prices:
  • 50 Day Moving Avg: $22.04
  • 200 Day Moving Avg: $19.36
  • 52 Week Range: $14.03 - $24.00
  • Trailing P/E Ratio: 61.82
  • Foreward P/E Ratio: 40.80
  • P/E Growth: 1.64
Sales & Book Value:
  • Annual Revenue: $183.16 million
  • Price / Sales: 3.73
  • Book Value: $6.56 per share
  • Price / Book: 3.11
  • EBITDA: $23.56 million
  • Net Margins: 6.16%
  • Return on Equity: 7.41%
  • Return on Assets: 4.95%
  • Debt-to-Equity Ratio: 0.30%
  • Current Ratio: 5.91%
  • Quick Ratio: 4.88%
  • Average Volume: 179,938 shs.
  • Beta: 0.92
  • Short Ratio: 3.74

Frequently Asked Questions for CryoLife (NYSE:CRY)

What is CryoLife's stock symbol?

CryoLife trades on the New York Stock Exchange (NYSE) under the ticker symbol "CRY."

How were CryoLife's earnings last quarter?

CryoLife, Inc. (NYSE:CRY) released its quarterly earnings data on Wednesday, April, 26th. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.05. The firm earned $45.10 million during the quarter, compared to analysts' expectations of $44.64 million. CryoLife had a net margin of 6.16% and a return on equity of 7.41%. The firm's quarterly revenue was up 4.9% on a year-over-year basis. During the same period in the previous year, the company earned $0.10 earnings per share. View CryoLife's Earnings History.

When will CryoLife make its next earnings announcement?

CryoLife is scheduled to release their next quarterly earnings announcement on Monday, October, 30th 2017. View Earnings Estimates for CryoLife.

Where is CryoLife's stock going? Where will CryoLife's stock price be in 2017?

4 analysts have issued twelve-month target prices for CryoLife's shares. Their forecasts range from $20.00 to $26.00. On average, they expect CryoLife's share price to reach $23.63 in the next year. View Analyst Ratings for CryoLife.

Who are some of CryoLife's key competitors?

Who are CryoLife's key executives?

CryoLife's management team includes the folowing people:

  • James Patrick Mackin, Chairman of the Board, President, Chief Executive Officer
  • D. Ashley Lee CPA, Chief Financial Officer, Chief Operating Officer, Executive Vice President
  • James M McDermid, Chief Human Resource Officer
  • John Davis, Senior Vice President - Global Sales and Marketing
  • William Matthews, Senior Vice President - Operations, Quality, and Regulatory
  • Amy D. Horton CPA, Chief Accounting Officer
  • Jean F. Holloway, Chief Compliance Officer, Vice President, General Counsel, Secretary
  • Scott B. Capps, Vice President - Clinical Research
  • David C. Gale Ph.D., Vice President - Research & Development
  • James Bullock, Director

Who owns CryoLife stock?

CryoLife's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Shell Asset Management Co. (0.28%). Company insiders that own CryoLife stock include Amy Horton, C Elkins Ronald, David Ashley Lee, James Benson, James P Mackin, Ronald D Mccall and Scott B Capps. View Institutional Ownership Trends for CryoLife.

Who bought CryoLife stock? Who is buying CryoLife stock?

CryoLife's stock was purchased by a variety of institutional investors in the last quarter, including Shell Asset Management Co.. View Insider Buying and Selling for CryoLife.

How do I buy CryoLife stock?

Shares of CryoLife can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CryoLife's stock price today?

One share of CryoLife stock can currently be purchased for approximately $20.40.

MarketBeat Community Rating for CryoLife (NYSE CRY)
Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  139 (Vote Outperform)
Underperform Votes:  96 (Vote Underperform)
Total Votes:  235
MarketBeat's community ratings are surveys of what our community members think about CryoLife and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for CryoLife (NYSE:CRY) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $23.63 (15.81% upside)
Consensus Price Target History for CryoLife (NYSE:CRY)
Price Target History for CryoLife (NYSE:CRY)
Analysts' Ratings History for CryoLife (NYSE:CRY)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/11/2017Lake Street CapitalBoost Price TargetBuy$26.00N/AView Rating Details
10/9/2017Canaccord GenuityReiterated RatingBuy$25.00N/AView Rating Details
4/28/2017Northland SecuritiesReiterated RatingBuy$23.50LowView Rating Details
2/17/2017Ladenburg Thalmann Financial ServicesUpgradeNeutral -> Buy$20.00N/AView Rating Details
7/27/2016Piper Jaffray CompaniesReiterated RatingOverweight$16.00N/AView Rating Details
(Data available from 10/23/2015 forward)


Earnings History for CryoLife (NYSE:CRY)
Earnings by Quarter for CryoLife (NYSE:CRY)
Earnings History by Quarter for CryoLife (NYSE CRY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2017$0.11N/AView Earnings Details
7/24/2017Q2 2017$0.10$0.12$47.02 million$47.80 millionViewN/AView Earnings Details
4/26/2017Q1 2017$0.04$0.09$44.64 million$45.10 millionViewN/AView Earnings Details
2/15/2017Q416$0.09$0.12$46.92 million$45.00 millionViewListenView Earnings Details
10/26/2016Q316$0.05$0.13$44.90 million$45.30 millionViewListenView Earnings Details
7/25/2016Q216$0.02$0.13$35.50 million$47.10 millionViewListenView Earnings Details
4/27/2016Q116$0.02$0.10$40.50 million$43.00 millionViewListenView Earnings Details
2/15/2016Q415$0.05$0.13$40.04 million$39.80 millionViewListenView Earnings Details
10/27/2015Q315$0.01$0.10$38.17 million$36.70 millionViewListenView Earnings Details
7/28/2015Q215$0.03$35.57 million$35.50 millionViewListenView Earnings Details
4/28/2015Q115$0.01($0.01)$36.55 million$33.80 millionViewListenView Earnings Details
2/17/2015Q414$0.05$0.04$37.42 million$37.20 millionViewListenView Earnings Details
10/28/2014Q314$0.05$0.08$37.70 million$37.10 millionViewListenView Earnings Details
7/24/2014Q214$0.05$0.08$35.72 million$34.69 millionViewListenView Earnings Details
4/29/2014Q114$0.07$0.04$37.30 million$35.73 millionViewListenView Earnings Details
2/20/2014Q413$0.35$0.31$34.90 million$35.50 millionViewListenView Earnings Details
10/29/2013Q313$0.05$0.12$35.51 million$36.30 millionViewListenView Earnings Details
7/25/2013Q2 2013$0.07$0.08$35.63 million$33.50 millionViewListenView Earnings Details
4/30/2013Q1 2013$0.07$0.08$35.04 million$35.50 millionViewListenView Earnings Details
2/14/2013Q4 2012$0.05$0.08$33.58 million$32.80 millionViewListenView Earnings Details
10/30/2012Q312$0.04$0.08$32.45 million$33.40 millionViewN/AView Earnings Details
7/31/2012$0.05$0.10ViewN/AView Earnings Details
4/26/2012$0.05$0.04ViewN/AView Earnings Details
2/16/2012$0.06$0.07ViewN/AView Earnings Details
10/27/2011$0.08$0.07ViewN/AView Earnings Details
7/28/2011$0.06$0.12ViewN/AView Earnings Details
4/28/2011$0.08$0.09ViewN/AView Earnings Details
2/17/2011$0.07$0.08ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for CryoLife (NYSE:CRY)
2017 EPS Consensus Estimate: $0.27
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.04$0.06$0.05
Q2 20172$0.07$0.07$0.07
Q3 20172$0.05$0.07$0.06
Q4 20172$0.09$0.09$0.09
Q1 20181$0.03$0.03$0.03
Q2 20181$0.07$0.07$0.07
(Data provided by Zacks Investment Research)


Current Dividend Information for CryoLife (NYSE:CRY)
Most Recent Dividend:12/18/2015
Dividend Yield:0.00%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:0.00% (Trailing 12 Months of Earnings)
0.00% (Based on This Year's Estimates)
0.00% (Based on Next Year's Estimates)
Track Record:4 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for CryoLife (NYSE:CRY)

Dividend History by Quarter for CryoLife (NYSE CRY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for CryoLife (NYSE:CRY)
Insider Ownership Percentage: 6.00%
Institutional Ownership Percentage: 68.36%
Insider Trades by Quarter for CryoLife (NYSE:CRY)
Institutional Ownership by Quarter for CryoLife (NYSE:CRY)
Insider Trades by Quarter for CryoLife (NYSE:CRY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/2/2017James BensonDirectorSell2,000$22.80$45,600.00View SEC Filing  
9/6/2017James P MackinCEOSell125,000$22.01$2,751,250.00View SEC Filing  
9/5/2017C Elkins RonaldDirectorSell1,000$22.00$22,000.00View SEC Filing  
9/5/2017James P MackinCEOSell43,050$22.09$950,974.50View SEC Filing  
6/27/2017Amy HortonVPSell9,577$20.00$191,540.00View SEC Filing  
2/22/2017Scott B CappsVPSell11,083$16.40$181,761.20View SEC Filing  
7/26/2016C Elkins RonaldDirectorSell2,000$14.00$28,000.00View SEC Filing  
6/1/2016Ronald D MccallDirectorSell10,000$11.56$115,600.00View SEC Filing  
5/10/2016James BensonDirectorSell5,000$12.22$61,100.00View SEC Filing  
4/15/2016C Elkins RonaldDirectorSell1,000$12.00$12,000.00View SEC Filing  
3/7/2016C Elkins RonaldDirectorSell2,000$11.18$22,360.00View SEC Filing  
3/4/2016James P MackinCEOBuy10,000$10.91$109,100.00View SEC Filing  
2/19/2016Scott B CappsVPSell15,000$10.30$154,500.00View SEC Filing  
2/18/2016David Ashley LeeCFOSell8,000$10.13$81,040.00View SEC Filing  
12/28/2015David Ashley LeeCFOSell700$11.00$7,700.00View SEC Filing  
11/30/2015David Ashley LeeCFOSell11,800$11.03$130,154.00View SEC Filing  
9/15/2015James BensonDirectorSell5,839$9.65$56,346.35View SEC Filing  
9/11/2015James BensonDirectorSell3,359$9.65$32,414.35View SEC Filing  
2/19/2015Steven G AndersonChairmanSell30,000$10.93$327,900.00View SEC Filing  
12/9/2014Bruce G AndersonVPSell3,900$10.29$40,131.00View SEC Filing  
11/25/2014Bruce G AndersonVPSell20,211$10.11$204,333.21View SEC Filing  
11/5/2014C Elkins RonaldDirectorSell4,000$10.08$40,320.00View SEC Filing  
11/3/2014James BensonDirectorSell10,000$10.22$102,200.00View SEC Filing  
9/8/2014Bruce G AndersonVPSell10,000$10.05$100,500.00View SEC Filing  
9/2/2014Steven G AndersonChairmanSell20,000$10.08$201,600.00View SEC Filing  
8/25/2014Bruce G AndersonVPSell5,000$10.05$50,250.00View SEC Filing  
8/18/2014Bruce G AndersonVPSell10,000$10.52$105,200.00View SEC Filing  
8/14/2014David Ashley LeeCFOSell10,000$10.51$105,100.00View SEC Filing  
8/13/2014David Ashley LeeCFOSell9,881$10.51$103,849.31View SEC Filing  
8/13/2014Jeffrey W BurrisVPSell11,000$10.50$115,500.00View SEC Filing  
7/29/2014C Elkins RonaldDirectorSell2,500$9.67$24,175.00View SEC Filing  
7/28/2014Bruce G AndersonVPSell5,000$9.48$47,400.00View SEC Filing  
7/28/2014Steven G AndersonCEOSell19,477$9.52$185,421.04View SEC Filing  
6/9/2014Amy HortonCAOSell2,500$9.26$23,150.00View SEC Filing  
5/16/2014David FronkVPSell8,952$8.61$77,076.72View SEC Filing  
5/13/2014Steven AndersonCEOSell30,523$9.00$274,707.00View SEC Filing  
5/6/2014Bruce AndersonVPSell16,870$8.83$148,962.10View SEC Filing  
11/26/2013Jeffrey BurrisVPSell5,000$10.50$52,500.00View SEC Filing  
11/11/2013Jeffrey BurrisVPSell5,000$10.00$50,000.00View SEC Filing  
11/7/2013Steven AndersonCEOSell100,000$9.38$938,000.00View SEC Filing  
10/29/2013C Elkins RonaldDirectorSell2,000$9.00$18,000.00View SEC Filing  
10/29/2013Jeffrey W BurrisVPSell5,000$9.00$45,000.00View SEC Filing  
8/27/2013Bruce AndersonVPSell4,500$6.33$28,485.00View SEC Filing  
8/8/2013Amy HortonCAOSell2,500$7.07$17,675.00View SEC Filing  
8/1/2013Ronald D MccallDirectorSell6,000$7.10$42,600.00View SEC Filing  
6/6/2013Ronald D MccallDirectorSell4,000$6.15$24,600.00View SEC Filing  
5/31/2013C Elkins RonaldDirectorSell2,250$6.15$13,837.50View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for CryoLife (NYSE:CRY)
Latest Headlines for CryoLife (NYSE:CRY)
Loading headlines, please wait.



CryoLife (CRY) Chart for Monday, October, 23, 2017

This page was last updated on 10/23/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.